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Antimicrobial peptides (AMPs) are critical components of host defense limiting bacterial
infections at the gastrointestinal mucosal surface. Bacterial pathogens have co-evolved
with host innate immunity and developed means to counteract the effect of endogenous
AMPs. However, molecular mechanisms of AMP resistance in Campylobacter, an
important human food-borne pathogen with poultry as a major reservoir, are still largely
unknown. In this study, random transposon mutagenesis and targeted site-directed
mutagenesis approaches were used to identify genetic loci contributing Campylobacter
resistance to fowlicidin-1, a chicken AMP belonging to cathelicidin family. An efficient
transposon mutagenesis approach (EZ::TN™ <KAN-2> Transposome) in conjunction with
a microtiter plate screening identified three mutants whose susceptibilities to fowlicidin-1
were significantly increased. Backcrossing of the transposon mutations into parent strain
confirmed that the AMP-sensitive phenotype in each mutant was linked to the specific
transposon insertion. Direct sequencing showed that these mutants have transposon
inserted in the genes encoding two-component regulator CbrR, transporter CjaB, and
putative trigger factor Tig. Genomic analysis also revealed an operon (Cj1580c-1584c)
that is homologous to sapABCDF, an operon conferring resistance to AMP in other
pathogens. Insertional inactivation of Cj1583c (sapB) significantly increased susceptibility
of Campylobacter to fowlicidin-1. The sapB as well as tig and cjaB mutants were
significantly impaired in their ability to compete with their wild-type strain 81–176
to colonize the chicken cecum. Together, this study identified four genetic loci in
Campylobacter that will be useful for characterizing molecular basis of Campylobacter
resistance to AMPs, a significant knowledge gap in Campylobacter pathogenesis.
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INTRODUCTION
Campylobacter species including C. jejuni and C. coli are the
most common bacterial causes of human gastroenteritis in
the United States and other developed countries (Allos, 2001).
Human Campylobacter illnesses are caused primarily by C. jejuni
(∼90%) and secondarily by C. coli (∼10%). Poultry are the
major reservoir of Campylobacter and thus the main source for
human campylobacteriosis (Friedman et al., 2000). As a comen-
sal, Campylobacter could establish persistent, benign infections
in chickens (up to 1010 CFU per gram of feces). To successfully
colonize and persist in intestinal tracts of animals and humans,
Campylobacter must have evolved a variety of mechanisms to
counteract hash in vivo conditions as well as host innate immu-
nity. However, we know less about Campylobacter pathogenicity
than we do about other prevalent pathogens, which impeded
the development of efficient intervention strategies to prevent
Abbreviations: AMP, antimicrobial peptide; F1, fowlicidin-1.
and control Campylobacter infections in humans and animal
reservoirs.
Endogenous antimicrobial peptides (AMPs) belong to the
most ancient and efficient components of host defense. Defensins
and cathelicidins are two major families of AMPs in humans and
animals. Both defensins and cathelicidines are important defense
AMPs expressed by epithelium in small intestine, consequently
limiting bacterial infections at the gastrointestinal mucosal sur-
face (Wehkamp et al., 2007). Despite the existence of a broad
diversity in AMP sequences and structures, the vast majority of
AMPs share a common theme in the mechanism of killing action
by disruption of membrane integrity (Yeaman and Yount, 2003;
Peschel and Sahl, 2006). Generally, AMPs directly interact with
target cells via initial electrostatic and hydrogen bond attraction,
then disrupt the structure or function of bacterial membrane by
permeating lipid bilayers, forming transmembrane pore, and ulti-
mately lead to cell death. However, transmembrane pore forming
is not the only mechanism of bacterial killing by AMP. AMPs may
also have intracellular targets (e.g., DNA gyrase, ribosome) and
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AMP-mediated bacterial death may occur as a result of several
independent or cooperative mechanisms of action (Yeaman and
Yount, 2003). Expression of defensins and cathelicidins is either
constitutive or inducible in gastrointestinal tract (Wehkamp et al.,
2007). Epithelial AMPs have been observed to be induced in
human intestinal epithelia upon infection by C. jejuni (Zilbauer
et al., 2005). Recently, a full panel of chicken defensins and cathe-
licidins (designated as “fowlicidins”) has been identified and char-
acterized (Lynn et al., 2004; Xiao et al., 2004, 2006; Bommineni
et al., 2007; van Dijk et al., 2007). These chicken AMPs displayed
potent and broad spectrum of antibacterial activity, highlight-
ing their role in host innate defense and in the development
of novel antimicrobial (peptide antibiotic) (Hancock and Sahl,
2006).
Bacterial pathogens have co-evolved with host innate defense
and developed means to curtail the effect of endogenous AMPs
(Yeaman and Yount, 2003; Peschel and Sahl, 2006). Different
AMP resistance mechanisms have been well characterized in
various enteric pathogens such as Salmonella enterica serovar
Typhimurium and Escherichia coli (Yeaman and Yount, 2003;
Peschel and Sahl, 2006). The best studied AMP resistance mecha-
nisms in Gram-negative bacteria involve (1) electrostatic repul-
sion of AMPs by modification of cell surface, (2) proteolytic
cleavage of AMPs, and (3) active extrusion of AMPs by drug
efflux pumps. Other mechanisms, such as capsule production,
changes in the composition of lipid fatty acids in membrane and
maintenance of appropriate membrane potential, have been also
implicated in AMP resistance. Covalent modification of LPS in
outer membrane via two-component regulatory systems (e.g.,
PhoP/PhoQ), which consequently reduces the negative charge
and/or membrane fluidity of LPS, has been identified as a major
mechanism in these Gram-negative pathogens (Ernst et al., 2001;
Yeaman and Yount, 2003; Peschel and Sahl, 2006). However, as
an important strategy to evade killing by innate immunity and by
potential peptide antibiotics, AMP resistance mechanisms are still
largely unknown in Campylobacter. Recently, it has been observed
that lipid A modification (Cullen and Trent, 2010; van Mourik
et al., 2010) and lipooligosaccharide (LOS) production (Lin et al.,
2009; Naito et al., 2010) could confer Campylobacter resistance to
polymyxin B, an AMP produced by bacterial species Paenibacillus
polymyxa, that has been successfully used as a model peptide
to study AMP resistance in many Gram-negative pathogens.
However, the polymyxin B resistance gene identified from our
recent study (Lin et al., 2009) did not contribute C. jejuni resis-
tance to endogenous AMPs (e.g., fowlicidins and bacteriocins),
strongly suggesting that polymyxin Bmay not be a good surrogate
for studying Campylobacter resistance to structurally unrelated
but physiologically relevant AMPs.
In this study, we chose fowlicidin-1 (F1), a cathelicidin
expressed in chicken intestine, as a model peptide to exam-
ine mechanisms of AMP resistance and identified three genetic
loci (cbrR, cjaB, and tig) involved in F1 resistance in C. jejuni
using an efficient in vivo transposon mutagenesis system. In addi-
tion, genomic analysis revealed an operon cj1580c-1584c that
shared homology to the sap (sensitivity to antimicrobial peptide)
operon that conferred resistance to AMP-mediated killing of dif-
ferent pathogens such as Salmonella (Parra-Lopez et al., 1993).
Site-directed mutagenesis of the sap operon showed that sapB
(cj1583c) is involved in F1 resistance in C. jejuni. Chicken exper-
iments further demonstrated that these genes play an important
role in the colonization of Campylobacter in the intestine.
MATERIALS AND METHODS
BACTERIAL STRAINS, PLASMIDS, AND GROWTH CONDITIONS
The major bacterial strains and plasmids used in this study are
listed in Table 1. Among the 174 Campylobacter isolates used
for susceptibility test to chicken AMP F1, 154 isolates were
C. jejuni and 20 isolates were C. coli. These Campylobacter strains
were isolated from different hosts and geographically diverse
locations described our previous study (Hoang et al., 2011a).
Campylobacter strains were routinely grown in Mueller–Hinton
(MH) broth (Difco) or MH agar at 42◦C under microaerophilic
conditions generated by using CampyGen Plus gas pack (Oxoid)
in an enclosed jar. E. coli strains were grown in Luria–Bertani
(LB) broth with shaking (250 rpm) or on agar at 37◦C overnight.
Antibiotics kanamycin (Kan) or chloramphenicol (Cm) was
added in medium at a desired concentration when needed.
AMP SUSCEPTIBILITY TESTING
The susceptibilities of C. jejuni and C. coli isolates to F1 were
determined by a standard microtiter broth dilution method with
an inocula of 106 bacterial cells/ml as described previously (Lin
et al., 2002). Minimum inhibitory concentrations (MICs) were
determined by the lowest concentration of specific antimicro-
bial showing complete inhibition of bacterial growth after 24 h of
incubation at 42◦C. The chicken cathelicidin F1 (>95% purity)
was synthesized by Bio-Synthesis (Lewisville, TX).
In vitro SELECTION OF F1 RESISTANT C. jejuni
F1 was used as the selective agent to obtain spontaneous F1
resistant mutants in vitro. Briefly, C. jejuni 81–176 was grown
on F1-free MH agar plates overnight. The cells were harvested
and suspended in MH to final OD600 nm about 1.2. The cell
suspensions were plated on MH agar plates containing 16, 32,
or 64μg/ml of F1. Following four days of incubation under
microaerophilic conditions at 42◦C, the plates were checked for
the emergence of F1 resistant mutants. The F1 pre-adapted cells
were also used for in vitro selection of F1 resistant mutants.
Briefly, C. jejuni 81–176 F1 were grown in MH broth containing
sub-lethal concentration of F1 (4μg/ml) for five consecutive pas-
sages (2 days per passage). Following the fifth passages, cultures
were centrifuged, and the pellets were suspended in MH broth
to final OD600 nm about 1.2. The bacterial cells suspensions were
also plated MH agar plates with increasing concentrations of F1
for selecting F1 resistant mutant as described above.Mutants were
randomly selected, grown inMHbroth, and subjected toMIC test
together with the parent strain C. jejuni 81–176.
DNA ISOLATION AND NATURAL TRANSFORMATION
Chromosomal DNA was isolated from Campylobacter using the
Wizard Genomic Purification Kit (Promega) according to the
manufacturer’s instructions. Natural transformation (biphasic
method) was performed following standard procedure (Wang
and Taylor, 1990).
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Table 1 | Major bacterial strains and plasmids used in this study.
Strain or plasmid Description Source and reference
C. jejuni
JL241 NCTC 11168, human isolate Parkhill et al., 2000
JL28 81–176, human isolate with poor colonization ability in chicken Black et al., 1988
JL242 81–176, human isolate with high colonization ability in chicken Black et al., 1988
S3B C. jejuni strain isolated from a chicken Hoang et al., 2011a
JL599 JL28 derivative, cbrR::Kan This study
JL601 JL28 derivative, cjaB::Kan This study
JL602 JL28 derivative, tig::Kan This study
JL656 JL242 derivative, cbrR::Kan This study
JL657 JL242 derivative, cjaB::Kan This study
JL658 JL242 derivative, tig::Kan This study
JL623 JL241 derivative, cbrR::Kan This study
JL665 JL241derivative, cjaB::Kan This study
JL629 JL241derivative, tig::Kan This study
JL668 JL656/pCbrR This study
JL694 JL657/pCjaAB This study
JL695 JL658/pTig This study
JL624 C. jejuni S3B derivative, cbrR::Kan This study
JL631 C. jejuni S3B derivative, tig::Kan This study
JL805 C. jejuni S3B derivative, cjaB::Kan This study
JL697 JL242 derivative, cj1583c::Cm (sapB−) This study
JL706 JL241 derivative, cj1583c::Cm (sapB−) This study
JL719 JL242 derivative, cj1584c::Cm (sapA−) This study
JL793 JL242 derivative, cj1581c::Cm (saAD−) This study
JL792 JL242 derivative, cj1580c::Cm (sapF−) This study
E. coli
DH5α F−φ80lacZM15 (lacZYA-argF )U169 recA1 endA1 hsdR17 (r−k , m
+
k ) Invitrogen
phoA supE44 thi-1 gyrA96 relA1 λ−
JL690 DH5α containing pCjaAB This study
JL691 DH5α containing pTig This study
JL652 DH5α containing pCbrR This study
JL692 DH5α containing pcmSapB This study
JL48 Conjugation helper strain, DH5α containing plasmid RK2013 Lin et al., 2005
PLASMIDS
pRY111 E.coli-C.jejuni shuttle vector, Cmr Yao et al., 1993
pCbrR pRY111 derivative containing 1.5 kb cbrR gene plus its promoter region This study
pTig pRY111 derivative containing 1.6 kb tig gene plus its promoter region This study
pCjaAB pRY111 derivative containing 2.7 kb cjaAB operon plus its promoter region This study
pGEM-T Easy PCR cloning vector, Ampr Promega
pSapB pGEM-T Easy containing 2.0 kb Cj1583c (sapB) gene of JL241 This study
pcmSapB pSapB with Cm resistant gene inserted in Cj1583c (sapB) gene This study
RANDOM TRANSPOSON MUTAGENESIS AND SCREENING OF
MUTANTS WITH INCREASED SUSCEPTIBILITIES TO F1
C. jejuni 81–176 (JL28 in Table 1, F1 MIC = 8μg/ml) was
subjected to in vivo transposon mutagenesis using EZ::Tn5™
<KAN-2> Transposome (Epicentre) as detailed in our previous
publication (Lin et al., 2009). Briefly, one microliter of EZ-Tn5
<KAN-2> TnP transposome complex containing 25 ng trans-
poson was used to electroporate C. jejuni JL28 competent cells.
The Kanr transformants were individually picked and inoculated
in 96-well microplates. Following 24 h of incubation, cultures of
mutants were replicated into microtiter plates containing 4μg/ml
of F1. Those mutants that could not grow in F1-containing media
were selected from the initial plates and subjected to a second
screening to confirm increased sensitivities to F1. To confirm
specific genetic linkage between the transposon insertion and
the increased F1 susceptibility of each mutant, backcrossing of
the transposon mutations into wild-type C. jejuni 81–176 was
performed using natural transformation. The MICs of the back-
crossed mutants for F1 were determined together with parent
strain. The specific transposon insertion site of each mutant was
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determined by directly sequencing the genomic DNA (Lin et al.,
2009). Sequence analysis was performed using DNAStar software
package.
PCR AND RT-PCR
PCR was performed in a volume of 50μl containing 1mM
each deoxynucleoside triphosphate, 200 nM primers, 2.0mM
MgCl2, 100 ng of Campylobacter genomic DNA, and 2.5U of
Taq DNA polymerase (Promega) or Pfu Turbo DNA polymerase
(Stratagene). Cycling conditions varied according to the esti-
mated annealing temperature of the primers and the expected
sizes of the products (available upon request). RNA was extracted
fromC. jejuni strains using RNeasyMini Kit (Qiagen) followed by
treatment of RNA samples with RNase-free DNase (Qiagen). RT-
PCRwas conducted using theMasterAmp kit (Epicentre). Cycling
conditions for RT-PCR included an initial incubation at 55◦C for
30min and 94◦C for 2min followed by 40 cycles of 94◦C for 15s,
52◦C for 30s, and 68◦C for 1min, and a final extension at 68◦C
for 5min. A RT-PCR mixture lacking the RT was included as a
negative control.
COMPLEMENTATION IN trans
To complement cjaB mutation in isogenic CjaB mutant JL657,
a 2.7-kb complete cjaAB operon including its 174-bp upstream
and 193-bp downstream regions, was PCR amplified from NCTC
11168 using primer pairs of CjaAB-F and CjaAB-R (Table 2
and Figure 1). The PCR was performed using pfu DNA poly-
merase (Stratagene) and the blunt-ended PCR product was puri-
fied and ligated to shuttle vector pRY111 (Yao et al., 1993),
which was digested with SmaI prior to ligation. The ligation
Table 2 | Key oligonucleotide primers used in this study.
Primer DNA Sequence (5′–3′) Product size (kb)a Gene/Operon amplifieda
Tf-F TCATGAATTTCACCACTTAGCA 1.6 Cj0193c (tig)
Tf-R TGCTATCATTGAAGGCAAATTTTA
CjaAB-F TCGCCTAATGCCAAAGTTTC 2.7 cjaAB
CjaAB-R TCACCATCTGCATTGCATTTA
Cj0643-F GCAATGCGTATCAACAATCC 1.5 cbrR
Cj0643-R AAAAATTTCCTTTCTTTTGAAAAC
Cj1583c-F AAAAAGCCGAGGATTTGCTT 2.0 Cj1583c (sapB)
Cj1583c-R CTGTGGCTATAGCATGAACGA
Cj1584c-F CGGGTATATCTTGGCAGCAT 1.9 Cj1584c (sapA)
Cj1584c-R GAAACCCCTAAGTCCCCTTTT
Cj1582c-F CCTGTTTTGGTGCTCGTTTTA 1.5 Cj1582c (sapC)
Cj1582c-R GCTCTGCATCTTGCAAAACA
Cj1581c-F CGCTTTAATTCATTGGTGTTTC 1.5 Cj1581c (sapD)
Cj1581c-R TTAAAATTTTCCAAACCATCTTG
Cj1580c-F TTGATCGTTTGTGGCATTCT 1.5 Cj1580c (sapF )
Cj1580cR AAAAATCAAAGCCCAAGGAAA
CmF CGATTTAAATGCTCGGCGGTGTTCCTTT 0.8 cat
CmR CGATTTAAATGCGCCCTTTAGTTCCTAAAG
Sap4-F GTG CTA AAA CGCTTA GTTTTTAGTATT 0.6 sapB
Sap4-R AATCAAATGCTCTAAACGATTTAA AAA
Sap5-F GATGCAGTG ATTAATCTTGTATTT TCAGG 0.5 sapA
Sap5-R TCCATTTTACAAATTTATAAGGACCTG
Cj1583c-RT-F GGGCTTGATAAGCCTTTGCT 0.41 Cj1583c
Cj1583c-RT-R AAAACGAGCACCAAAACAGG
Cj1582c-RT-F TTTTTAGCCTTGCCTGCTTT 0.40 Cj1582c
Cj1582c-RT-R CCACCAAGCGCCTATAAAAA
Cj1581c-RT-F ACAAAGTGGAGTGGGCAAAA 0.38 Cj1581c
Cj1581c-RT-R AATCCAAACTAGGCTCAC
Cj1580c-RT-F GTGGTGCAGGTAAAAGCACA 0.32 Cj1580c
Cj1580c-RT-R GGCTTCTCCTCCGCTTAACT
ClpP-RT-F ATGATGAACTTGCCGCTTCT 0.40 Cj0192c
ClpP-RT-R GCTTCTTGTGCTGACATGAAAA
Cj0644-RT-F CAGGGGTGCATCCTTATGAA 0.32 Cj0644
Cj0644-RT-R GCAAATGTTCGCTTGCATTA
Cj0645-RT-F ATAATTGCGGAAATGGCAAG 0.41 Cj0645
Cj0645-RT-R GCTTCTTGTGCTGACATGAAAA
aProduct sizes and amplified genes refer to those of the relevant primer pair.
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mix was introduced into DH5α by transformation. One trans-
formant (JL690) with a plasmid bearing intact cjaAB operon
(pCjaAB) was created. The pCjaAB from JL690 was then trans-
ferred to JL657 by tri-parental conjugation using JL48 as a helper
strain (Lin et al., 2005). Similar approach was used to comple-
ment tig and cbrR mutations using primer pairs of Td-F/Td-R
and Cj0643-F/Cj0643-R, respectively (Table 2 and Figure 1). The
complemented strains, together with other related strains, were
subjected to AMP killing assay as described below.
CONSTRUCTION OF ISOGENIC sap MUTANTS
The putative sap genes (Cj1580c to cj1584c, Figure 1) were inac-
tivated by insertional mutagenesis according to our previous
publication (Lin et al., 2005). Taking sapB (Cj1583c) as an exam-
ple, an approximately 2 kb fragment was PCR amplified from
genomic DNA of 11168 (JL241) by using primer pair Cj1583c-
F and Cj1583c-R (Table 2). The PCR product was cloned into
pGEM-T Easy vector (Promega) to generate pSapB (Table 1). The
chloramphenicol resistance gene cassette (cat) was PCR ampli-
fied from plasmid pRY111 (Yao et al., 1993) by using PfuUltra®
High-Fidelity DNA polymerase (Stratagene) and primers of CmF
and CmR (Table 2). The resulting blunt-ended PCR product
was purified and ligated into pSapB vector, which was digested
with SwaI prior to ligation, to generate mutant construct pcm-
SapB (Table 1). The construct pcmSapB, which serves as suicide
vector, was then introduced into 81–176 (JL242) by natural trans-
formation. One transformant, designated JL697, was selected
on MH agar containing 5μg/ml of Cm. The inactivation of
putative sapB (Cj1583c) in JL697 was confirmed by PCR (data
not shown). A similar site-directed mutagenesis approach was
used to create isogenic Cj1584c (sapA), Cj1582c (sapC), Cj1581c
(sapD), and Cj1580c (sapF) mutants of 81–176 by using primers
pairs Cj1584c-F/R Cj1582c-F/R, Cj1581c-F/R, and Cj1580c-F/R,
respectively (Table 2). Notably, due to the absence of a tran-
scriptional terminator downstream of the cat gene and the same
orientation of the cat gene with respect to the inactivated gene,
inactivation of specific gene likely has no polar effect on the
downstream genes; thus, construction of the individual isogenic
sapmutants may help us to evaluate their relative contribution to
fowlicidin resistance.
AMP KILLING ASSAY
The C. jejuni mutants together with their parent strains were
subjected to AMP killing assay using 96-well plate as described
previously (Mount et al., 2010) with minor modifications. The
AMPs used in killing assay include chicken cathelicidin F1,
chicken defensin AvBD9 (kindly provided by Dr. Guolong Zhang,
Oklahoma State University), bacteriocin OR-7 and E-760 (Lin
et al., 2009), and those purchased from Sigma (polymyxin
B, colistin, cecropin A, gramicidin, and magananin). Briefly,
Campylobacter strains were grown inMH broth to mid-log phase,
and the cells were washed with MH broth and diluted to approx-
imately 106 CFU/ml in MH broth. A volume of 180μl of the
diluted cells was mixed with 20μl MH broth (control) or AMP
stock solution (concentration of 10-fold MIC of specific AMP)
(treatment). The plates were incubated under microaerophilic
conditions at 42◦C for 2 h. After 2 h incubation, 20μl of bacterial
culture were taken and serially diluted in MH broth and plated
onto MH agar plates. The number of CFU was enumerated after
two days of incubation under microaerophilic conditions at 42◦C.
Percentage survival was calculated by dividing the CFU number
of bacteria incubated with AMP relative to those incubated in the
presence of MH broth and then multiplied by 100. All assays were
carried out in triplicate and two independent experiments were
FIGURE 1 | Genomic organization and features of the cjaAB, tig, cbrR,
and sap operons in C. jejuni 81–176. The identified ORFs are indicated by
boxed arrows. The corresponding gene loci in C. jejuni NCTC 11168 are
described in boxed arrows. The locations of major primers used in this study
are indicated by arrows. The location and orientation of antibiotic resistance
cassette are indicated below each inactivated gene. For sap operon, the aa
identity of the putative sap gene to its homolog in S. enreica serovar
Typhimurium LT2 is listed in parentheses.
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performed. The significance of differences in susceptibility was
determined using the Student’s t-test.
CHICKEN COLONIZATION EXPERIMENT
Because cbrR mutant has been evaluated for its colonization abil-
ity in a previous study (Raphael et al., 2005), only sapB as well
as tig and cjaB mutants were evaluated together with their parent
strain 81–187 in this study. The chicken study was approved by the
Institutional Animal Care and Use Committee at The University
of Tennessee. Briefly, one-day-old broiler chickens were obtained
from a commercial hatchery (Hubbard Hatchery, Pikesville, TN).
The chickens were negative for Campylobacter as determined by
culturing cloacal swabs prior to use in this study. These chick-
ens were randomly assigned into three treatment group (10 or 11
chicks/group). At four days of age, each chicken was orally inoc-
ulated with a 1:1 mixture of wild type 81–176 (JL242) and its
isogenic cjaB mutant (group I), tig mutant (group II), or sapB
mutant (group III), with a dose of approximately 107CFU of bac-
teria per chick. For each group, five birds were euthanized and
cecal contents were collected at 3, and 10 days post-inoculation
(DPI). The cecal contents from each bird were weighed and
diluted in MH broth. The cecal suspensions were duplicate
plated onto MH agar plates with Campylobacter-specific selec-
tive supplements (Oxoid, UK) for total Campylobacter enumer-
ation and onto selective plates supplemented with appropriate
antibiotics (30μg/ml of Kan or 6μg/ml of Cm) for the specific
mutant numbers in each sample. The plating media were tested
prior to use to ensure that they supported the growth of the
mutant strains. Notably, before inoculation, the motility of the
wild-type and its isogenic mutants were confirmed to be at a
comparable level.
The number of CFU per gram of cecal contents was calculated
for each chicken and was used as an indicator of the colonization
level. The detection limit of the plating methods was 100CFU/g
of cecal contents. The bird fromwhich noCampylobacter colonies
were detected was assigned a conservative value of 99CFU/g of
cecal contents for the purpose of calculating means and for statis-
tical analysis. Student’s t-test was used to examine the significance
of differences in Campylobacter colonization levels (log trans-
formed CFU). A P-value of <0.01 was considered significant.
RESULTS
EMERGENCE OF ACQUIRED F1 RESISTANCE IN Campylobacter
Emergence of acquired AMP resistance is an important issue
related to bacterial pathogenesis and development of sustain-
able peptide antibiotics (Yeaman and Yount, 2003; Hancock and
Sahl, 2006; Peschel and Sahl, 2006). Previous studies suggested
that high-level resistance to host endogenous AMP is difficult
to develop (Peschel and Sahl, 2006), which is also supported by
our recent Campylobacter work on the development of acquired
resistance to polymyxin B (a widely used model peptide) and
bacteriocins (the AMPs produced by bacteria) (Lin et al., 2009;
Hoang et al., 2011a,b). Thus, in this study we first performed
a screening to determine if high-level F1 resistance is observed
in various Campylobacter isolates. Standard MIC test using MH
broth showed that majority of C. jejuni and C. coli isolates
exhibited low MIC to F1, ranging from 4μg/ml to 8μg/ml.
Among the 154 tested C. jejuni isolates, 58 and 85 showed
MICs of 4μg/ml and 8μg/ml, respectively. Only one C. jejuni
strain showed slightly higher MIC of 16μg/ml and only 6.5%
of C. jejuni isolates (10 out of 154) showed MICs ≤ 2μg/ml
(eight isolates with MIC of 2μg/ml and 2 with MIC of 1μg/ml).
C. coli showed similar pattern as C. jejuni and displayed MICs
of 0.5μg/ml (1 isolate), 1μg/ml (three isolates), 2μg/ml (three
isolates), 4μg/ml (eight isolates), and 8μg/ml (five isolates).
Together, the MIC survey here showed that none of the strains
displayed high-level acquired resistance to F1.
Our recent Campylobacter studies (Lin et al., 2009; Hoang
et al., 2011a,b) and work in other bacteria have demonstrated
that availability of AMP resistant mutant was very helpful
for examination of acquired AMP resistance using functional
genomics approaches, such as random transposon mutagene-
sis and microarray. Thus, in this study we also intended to
obtain an in vitro selected F1 resistant mutant. Different in vitro
selection methods consistently led to the emergence of F1 resis-
tant colonies on the selective plates containing 32, or 64μg/ml
of F1. Total 24 colonies were randomly selected for MIC test
together with their parent strain 81–176. However, after being
cultured in F1 free MH broth, none of these isolates displayed
higher MIC than 81–176 for F1, indicating all these mutants were
false-positive. Despite extensive efforts, no mutant with stable
acquired F1 resistance was selected in vitro. In summary, these
findings strongly suggest that endogenous AMPs are not favor-
able for the development of high-level acquired AMP resistance in
Campylobacter.
IDENTIFICATION OF GENETIC LOCI CONTRIBUTING TO F1
RESISTANCE BY RANDOM TRANSPOSONE MUTAGENESIS
Although we failed to obtain C. jejuni mutants with acquired
F1 resistance, examination of intrinsic AMP resistance in wild-
type C. jejuni strains would fill a significant knowledge gap and
also likely shed light on the mechanisms of acquired AMP resis-
tance in Campylobacter. Thus, in this study a library containing
4800 Kanr mutants were generated for screening the mutants
with an increased susceptibility to F1. Three mutants displaying
increased sensitivity to F1 were identified. Backcrossing of the
transposon mutations into C. jejuni 81–176 further confirmed
that the F1 sensitive phenotype in each mutant was linked to
the gene with a specific transposon insertion. Direct sequencing
of the mutant genomic DNA using transposon-specific primers
showed the EZ::TN <KAN-2> transposon inserted into Cj0981c,
Cj0193c, and Cj0643 (Figure 1). All the transposon insertions
occurred in the coding regions of corresponding genes. The ori-
entations of Kanr cassette within transposon in each mutant were
the same as the corresponding disrupted gene (Figure 1). The
Cj0981c, Cj0193c, and Cj0643 encode transporter CjaB, putative
trigger factor Tig, and the response regulator CbrR, respectively.
F1 killing assay further confirmed that the insertional inactiva-
tion of cbrR, tig, or cjaB led to significantly increased susceptibility
of C. jejuni 81–176 to F1 (Figure 2A). This phenotype was also
observed in other strain background (C. jejuni NCTC 11168 and
S3B) (Figure 2B). However, mutation of these genes did not con-
fer significantly enhanced susceptibility of these mutants to other
tested AMPs (data not shown).
Frontiers in Cellular and Infection Microbiology www.frontiersin.org March 2012 | Volume 2 | Article 32 | 6
Hoang et al. Fowlicidin resistance in Campylobacter
FIGURE 2 | Role of cbrR, tig, cjaB and sapB in F-1 resistance in different
C. jejuni strains. (A) Susceptibilities of wild-type 81–176 and its cbrR, tig,
and cjaB mutant constructs to F1. (B) Effects of mutations in cbrR, tig, and
cjaB on the susceptibilities of C. jejuni NCTC 11168 and S3B to F1.
(C) Inactivation of sapB increased susceptibilities of 81–176 and NCTC 11168
to F1. Log-phase cells in MH broth were supplemented with F1 at
final concentration of 8μg/ml and incubated for 2 h at 42◦C under
microaerophic condition. Samples were diluted and plated on MH agar
plates to determine bacterial viability. Percentage survival was calculated
by dividing the CFU number of bacteria incubated with AMP relative to
those incubated in the presence of MH broth and then multiplied by 100.
Each data point represents the mean value obtained from two independent
experiments with triplicate measurements in each independent
experiment.
Complementation of cjaB mutation in JL657 completely
restored F1 resistance level back to the level of parent strain 81–
176 (Figure 2A), which is consistent with the report that the cjaB
and its upstream gene cjaA formed an operon (Wyszynska et al.,
2006; see Figure 1). Complementation of CbrR and Tig mutant
had little effect on sensitivity of the mutants to F1 (Figure 2A),
likely due to the polar effect of the transposon mutation on the
downstream genes in the same operon. The cbrR, a gene encoding
a two-component response regulator required for bile salt resis-
tance of Campylobacter (Raphael et al., 2005), appears to form an
operon together with its nine downstream genes (Figure 1). For
example, the stop codon of cbrR and start codon of tatD overlap
by 10 nucleotides (Figure 1). There is no intergenic space between
the stop codon of tig and the start codon of downstream clpP, sug-
gesting these two genes are organized into an operon. The clpP
is separated from its downstream gene def by a 28 bp intergenic
region which is predicted to contain promoter sequence. Thus,
tig operon likely contains two genes (tig and clpP) (Figure 1).
RT-PCR using specific primers (Table 2) showed that clp and
tatD/Cj0645 were barely transcribed in tig and cbrR mutants,
respectively, while all the genes were expressed normally in wild-
type 81–176 (data not shown), indicating that the insertional
mutation in tig and cbrR caused a polar effect on the downstream
genes.
SapB CONTRIBUTES TO F1 RESISTANCE IN C. jejuni
The sap (sensitivity to antimicrobial peptide) operon confers
resistance to AMP-mediated killing of different pathogens such as
Salmonella (Parra-Lopez et al., 1993) and Haemophilus influenza
(Mason et al., 2005) although the exact mechanisms of how Sap
transporters protect the cells from AMP attack remain unclear.
Analysis of NCTC 11168 genome revealed that the operon
Cj1580c-Cj1584c shared homology to the identified sap operon in
S. enreica serovar Typhimurium LT2 with identical genetic com-
ponents and organization, which include (Figure 1), in which
sapA (Cj1584c) encodes a putative periplasmic peptide bind-
ing protein and sapB (Cj1583c) encodes a membrane permease.
Comparative genomic analysis of published C. jejuni genomes
showed that the putative sapABCDF operon is highly conserved
in C. jejuni with nucleotide sequence identity ranging from 98 to
100%. This observation was further confirmed by our PCR survey
using sapB specific primer pair (Sap4-F/R, Table 2) and sapA spe-
cific primer pair (Sap5-F/R, Table 2) for 27 diverse Campylobacter
strains (21 C. jejuni strains and 6 C. coli isolates), in which major-
ity of strains contain sap operon as reflected by the positive PCR
results (23 out of 27).
Isogenic SapA, SapB, SapD, and SapF mutants of 81–176 were
successfully created in C. jejuni 81–176 (Table 1). Mutation in
SapC could not be generated after repeated attempts. RT-PCR
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analysis using specific primers (Table 2) indicated that insertional
inactivation using Cm resistance gene marker did not cause polar
effect on the transcription of the genes (Cj1582c, Cj1581c, and
Cj1580c) downstream of specific mutated gene (data not shown).
As shown in Figure 2C, inactivation of SapB caused significantly
in increased sensitivity to F1 in both 81–176 and 11168 strain
background. However, mutation of other individual sap genes
including sapA (Cj1584c), sapD (Cj1581c), and sapF (Cj1580c)
(Figure 1) did not alter sensitivity of the mutants to F1 (data not
shown). In addition, isogenic sapBmutant did not display signifi-
cantly increased susceptibilities to other tested AMPs with diverse
sequence and structure (data not shown).
INACTIVATION OF SapB, CjaB, AND Tig REDUCED Campylobacter
COLONIZATION IN CHICKENS
It has been demonstrated that cbrR is required for optimal colo-
nization of Campylobacter in chickens (Raphael et al., 2005). In
this study, we compared colonization ability of the isogenic sapB,
cjaB, and tig mutants to their parent strain 81–176 using mixed
infection in chicken. As shown in Figure 3, inactivation of the
sapB, cjaB, or tig gene greatly impaired the colonization ability
of C. jejuni 81–176 in chickens. Specifically, when 81–176 and
its specific isogenic mutant were co-inoculated into a group of
chickens, the colonization level of the specific mutant was signifi-
cantly lower than that of 81–176 at 3 and 10 days post-inoculation
(DPI). In particular, by 10 DPI, the specific mutant of C. jejuni
81–176 (tig−, cjaB−, or sapB− mutant) was no longer detected in
any of the cecal samples collected from the chickens inoculated
with mixture of 81–176 and its isogenic mutant. It is important
to mention that both 81–176 and the isogenic mutants showed
similar growth patterns in MH broth (data not shown). We also
performed an identical in vitro competition assay in MH broth;
all the mutants were not outcompeted by 81–176 and the iso-
genic mutant displayed an in vitro competitive index (ratio of
the mutant to wild-type strain at early stationary phase) of about
1, indicating that growth rate of these mutants is similar to its
wild-type 81–176.
DISCUSSION
Development of AMP resistance is an important strategy utilized
by many bacterial pathogens including various enteric bacteria
to evade host innate immunity and to colonize in various host
niches successfully (Ernst et al., 2001; Yeaman and Yount, 2003;
Peschel and Sahl, 2006). However, it is still largely unknown how
important AMP resistance is for Campylobacter infection and
what is the molecular basis of AMP resistance in Campylobacter.
FIGURE 3 | Inactivation of SapB, CjaB, or Tig impaired C. jejuni 81–176
colonization of chickens. Three chicken groups were inoculated with a
1:1 mixture of wild type 81–176 and its isogenic SapB mutant (A), CjaB
mutant (B), or Tig mutant (C). For each group, five to six birds were
euthanized at the indicated days post-inoculation (DPI) and the cecal
contents were collected and used for CFU enumeration. Each symbol
indicates the log10 number of CFU/g of cecal contents for a single
chicken. The horizontal bars indicate the means of groups at the
indicated times. The horizontal dash line indicates the limit of
detection.
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To date, there are no any animal knockout experiments demon-
strating the critical role of specific host AMP in defense against
Campylobacter. However, it has been well established that AMPs
(primarily defensins and cathelicidins) are a major component
of host innate immunity systems against enteric pathogens. For
example, mice deficient in cathelicidin or defensins production
are more susceptible to intestinal infections by enteric pathogens
(Wilson et al., 1999; Iimura et al., 2005). Thus, both defensins and
cathelicidins are important AMPs expressed in the small intes-
tine to protect host against pathogens (Wehkamp et al., 2007).
Zilbauer et al. (2005) also observed that epithelial AMPs were
induced in human intestinal epithelia upon infection by C. jejuni.
In chickens, although different AMPs including the F1 used in this
study are expressed in the intestine, the concentrations of spe-
cific AMP in any of intestinal niches are still unknown. Specific
knock out model should be developed to determine if chicken
deficient in F1 production is more susceptible for Campylobacter
infection. Notably, colonization of Campylobacter in chicken
and other hosts is determined by delicate interactions between
Campylobacter and host in which many determinants in addition
to AMP are involved. However, given the intimate interaction of
Campylobacter with intestinal mucosa and the intracellular stage
during systemic Campylobacter infection in humans (invasion of
epithelial cells and engulfment by phagocytes), Campylobacter
should have co-evolved with host innate defense and developed
means to curtail the effect of endogenous AMPs for successful
colonization as observed in other enteric pathogens (Ernst et al.,
2001; Yeaman and Yount, 2003; Peschel and Sahl, 2006). However,
mechanisms of AMP resistance in Campylobacter are still largely
unknown.
We have initiated determination of AMP resistance mecha-
nisms in Campylobacter using polymyxin B as a model peptide
and have defined seven genetic loci (e.g., galU required for LOS
production) contributing to C. jejuni resistance to polymyxin B
(Lin et al., 2009). Recent work also showed that production of
specific LOS (Naito et al., 2010) and lipidA modification (Cullen
and Trent, 2010; van Mourik et al., 2010) were required for
polymyxin B resistance in C. jejuni, likely due to their role in elec-
trostatic shielding against polymyxin B. Polymyxin B has been
successfully used as a model peptide to study AMP resistance
in many Gram-negative pathogens although polymyxin B bears
little structural resemblance to the host defense AMPs (Ernst
et al., 2001; Yeaman and Yount, 2003; Peschel and Sahl, 2006).
However, our previous study (Lin et al., 2009) strongly suggested
that polymyxin B may not be a good surrogate for studying
AMP resistance in Campylobater. In addition, examination of
Campylobacter resistance to bacteriocins revealed a different set
of genes which are not involved in resistance to polymyxin B and
other endogenous AMPs (Hoang et al., 2011a). Therefore, direct
usage of natural host AMP as a model peptide may generate phys-
iologically relevant information for Campylobacter pathogenesis.
We chose to use F1 as a surrogate of host defense peptides
because of following reasons. First, unlike defensins, the short
α-helical fowlicidin-1 (F1) can be easily synthesized at reason-
able cost for large scale screening. Second, cathelicidins including
F1 are important AMPs expressed in intestine and displayed
potent bactericidal effect (Lynn et al., 2004; Xiao et al., 2004,
2006; Peschel and Sahl, 2006; Bommineni et al., 2007). In addi-
tion, some genes (e.g., phoPQ) required for cathelicidin resistance
could also involve resistance to structurally unrelated AMPs such
as defensins (Ernst et al., 2001; Winfield and Groisman, 2004).
Thus, genes contributing to F1 resistance may be important for
in vivo colonization ofC. jejuni in the host. Finally, F1 is produced
by chicken, an animal model used in this study, which would
make us well correlate the findings obtained from in vitro and
in vivo studies.
In this study, inactivation of SapB, CjaB, Tig, and CbrR
led to increased susceptibilities to F1 in different C. jejuni
strain background. In addition, chicken experiment also showed
impaired colonization ability of these mutants in the intestine.
The Sap operon encode ABC-type transporter system and have
been demonstrated to involve AMP resistance in various Gram-
negative bacteria; mutation of the sap operon also resulted in
impaired colonization in animal models (Parra-Lopez et al., 1993;
Lopez-Solanilla et al., 1998; Chen et al., 2000; McCoy et al.,
2001; Lupp et al., 2002; Mason et al., 2005, 2006; Mount et al.,
2010). The exact mechanisms of how Sap transporters protect
the cells from AMP attack remain unclear. In this study, we
demonstrated the role of sapB in Campylobacter resistance to F1;
however, mutation of sapB in C. jejuni did not lead to signifi-
cantly increased susceptibilities to other natural AMPs.We should
interpret this finding cautiously. The C. jejuni sap may still inter-
act to other structurally unrelated AMPs with lower efficiency
than F1; however, limited expression level of Sap in our in vitro
killing assay system may diminish the susceptibility difference
between Sap mutant and wild-type strain. Mason et al. (2003,
2005) reported that sap expression of H. influenza is greatly up-
regulated in vivo. Therefore, the sap operon of Campylobacter is
possible up-regulated during in vivo infection and such enhanced
expression of sap may ultimately confer C. jejuni resistance to
various endogenous AMPs, leading to greatly impaired intestinal
colonization observed in this study (Figure 3A). This hypothesis
needs to be examined in the future. In terms of CjaAB operon,
our chicken study has clearly showed its role in C. jejuni colo-
nization in the intestine, likely due to its contribution to AMP
resistance. The CjaB was predicted as an inner membrane trans-
porter with unknown function in Campylobacter (Wyszynska
et al., 2006). The underlying mechanism for CjaAB conferring
F1 resistance is not clear. It has been observed that efflux pumps
are involved in AMP resistance in various bacteria (Yeaman and
Yount, 2003; Peschel and Sahl, 2006). Recently, we also demon-
strated that CmeABC efflux pump is required for Campylobacter
resistance to bacteriocins (Hoang et al., 2011a). Therefore, it
is likely that CjaAB function as an efflux pump to extrude F1
out of cells for resistance. However, it is equally possible that
CjaAB may function as an influx transporter and facilitate trans-
portation of F1 to Campylobacter cytoplasm where F1 is targeted
for degradation.
Given the failure of complementation and lack of expression
of the genes downstream of the inactivated tig and cbrR, the
phenotypes of isogenic tig and cbrR mutants observed in this
study are likely caused by other gene(s) in the same operon
or the coordination of all genes within the operon (Figure 1).
Trigger factor Tig was found highly conserved in eubacteria,
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functioning as a chaperon to interact with newly synthesized
polypeptides, assist protein folding, and plays a vital role in bac-
terial virulence (Rassow and Pfanner, 1996; Martinez-Hackert
and Hendrickson, 2009). The gene immediately downstream of
tig in Campylobacter was annotated as clpP that function as a
protease to degrade misfolding peptides in other bacteria (Frees
et al., 2007). Notably, the ClpP homolog of Bacillus anthracis
has been demonstrated to be involved in resistance to AMPs
human cathelicidin LL-3 (McGillivray et al., 2009). Therefore,
since degradation of AMPs by protease is one of mechanisms
used by bacteria to resist endogenous AMPs (Yeaman and Yount,
2003), the C. jejuni ClpP may involve proteolytic cleavage and
play a role in virulence by mediating the role in AMP resis-
tance. This hypothesis needs to be examined in the future.
Recently, Cohn et al. (2007) has characterized the C. jejuni ClpP
and observed that ClpP influenced heat tolerance of C. jejuni.
Therefore, the impaired colonization of tig mutant observed in
this study also could be attributed to the temperature sensitivity
due to inactivation of ClpP. Similarly, cbrR and nine of its down-
stream genes appear to organize into an operon (Figure 1) and
some downstream genes may be involved in AMP resistance in
C. jejuni. For example, Cj0649 encodes a beta-barrel LptD-like
protein and the LptD in Pseudomonas aeruginosa appeared to
act as a dominant resistance marker against cathelicidins likely
due to its function in the assembly of LPS in the outer leaflet
of the outer membrane (Srinivas et al., 2010). However, the
two component regulators identified in this study (CbrR) and
in our recent work (RacR) (Lin et al., 2009) may still involve
Campylobacter resistance to AMPs. In response to environmental
cues via two-component regulatory systems (e.g., PhoP/PhoQ),
Gram-negative bacteria can add covalent modification to LPS and
consequently reduce the negative charge and/or membrane fluid-
ity of LPS and protect themselves from attack by AMPs, which
has been a major AMP resistant mechanism in enteric bacteria
(Ernst et al., 2001; Yeaman and Yount, 2003; Peschel and Sahl,
2006). Mutations occurred in two-component regulators could
result in sustained, acquired AMP-resistance. To hunt potential
two-component regulators required for AMP resistance, we have
performed sequencing of nine regulators, five histidine kinases,
and six signal transduction systems in polymyxin B resistant
mutant; but no sequence difference was observed in all selected
regulators between wild-type 81–176 and its polymyxin B resis-
tant derivatives (Hoang, 2010). Despite accumulating studies on
the functional characterization of two-component regulators in
C. jejuni, it is still unknown which environmental signals to
which these regulators respond. We speculate that some two-
component regulatory systems in C. jejuni can sense and integrate
multiple environmental cues in the host into a coordinated cellu-
lar response and promote Campylobacter resistance to AMPs in
different host niches. Testing this hypothesis relies on the iden-
tification of specific cues activating two-component regulatory
systems, a challenge issue to elucidate physiology and patho-
genesis role of two-component regulatory systems in bacterial
pathogens.
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